MedTrace Logo

Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin)

NCT03797469 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2021-11-11

No results posted yet for this study

Summary

This study seeks to test whether these over-the-counter nutritional supplements have an impact on patients' performance during visual field testing.

Conditions

  • Visual Field Defect, Peripheral
  • Glaucoma, Open-Angle

Interventions

DIETARY_SUPPLEMENT

Vitamin B3

3 tablets of 1000 mg each will be administered orally.

DIETARY_SUPPLEMENT

Pyruvate

2 tablets of 1500 mg each will be administered orally.

DIETARY_SUPPLEMENT

Placebo

Tablets will look identical to the supplements and the number of tablets will equal the amount of supplements provided.

Sponsors & Collaborators

Principal Investigators

  • Jeffrey M Liebmann, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03797469 on ClinicalTrials.gov